Literature DB >> 17456826

Invasive pneumococcal disease: the target is moving.

Timothy R Peters, Katherine A Poehling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17456826     DOI： 10.1001/jama.297.16.1825

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Invited commentary: Evaluating vaccination programs using genetic sequence data.

Authors:  M Elizabeth Halloran; Edward C Holmes
Journal:  Am J Epidemiol       Date:  2009-11-12       Impact factor: 4.897

2.  Economic evaluation of pneumococcal conjugate vaccination in The Gambia.

Authors:  Sun-Young Kim; Gene Lee; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2010-09-03       Impact factor: 3.090

3.  Lobar pneumonia treated by Musgrave Park physicians.

Authors:  John Hedley-Whyte; Debra R Milamed
Journal:  Ulster Med J       Date:  2009-05

Review 4.  A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States.

Authors:  John M McLaughlin; Eric A Utt; Nina M Hill; Verna L Welch; Edward Power; Gregg C Sylvester
Journal:  Hum Vaccin Immunother       Date:  2015-09-16       Impact factor: 3.452

5.  Self-reported pediatricians' management of the well-appearing young child with fever without a source: first survey in an European country in the anti-pneumococcal vaccine era.

Authors:  Elena Chiappini; Luisa Galli; Francesca Bonsignori; Elisabetta Venturini; Nicola Principi; Maurizio de Martino
Journal:  BMC Public Health       Date:  2009-08-19       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.